wr 99210 has been researched along with ornithine in 1 studies
| Studies (wr 99210) | Trials (wr 99210) | Recent Studies (post-2010) (wr 99210) | Studies (ornithine) | Trials (ornithine) | Recent Studies (post-2010) (ornithine) |
|---|---|---|---|---|---|
| 59 | 0 | 12 | 5,192 | 100 | 827 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, M; Subba Rao, G; Vijayakrishnan, R | 1 |
1 other study(ies) available for wr 99210 and ornithine
| Article | Year |
|---|---|
In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery.
Topics: Amino Acid Sequence; Antitubercular Agents; Binding Sites; Computational Biology; Crystallography, X-Ray; Drug Design; Folic Acid Antagonists; Humans; Hydrogen Bonding; Ligands; Methotrexate; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Molecular Sequence Data; Mycobacterium tuberculosis; Ornithine; Peptides; Pterins; Reproducibility of Results; Substrate Specificity; Tetrahydrofolate Dehydrogenase; Triazines; Tuberculosis | 2010 |